PUBLIC COMPANY
save$LPCNLipocine Inc.
$LPCNSalt Lake City, USupdated 21d ago
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 12Phase 22Marketed
Marketed
LPCN-1144
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Androgen receptor
Marketedbrexanolone
Post Partum Depression (Maternal Depression / Postnatal D…
GABA-A receptor; anion channel
Phase 2hydroxyprogesterone caproate
Premature Labor (Tocolysis)
Phase 2testosterone tridecanoate
Sarcopenia
Phase 1eltanolone
Epilepsy
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD
- phase2A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial
- phase2A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
- phase2The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Insider activity
source: SEC Form 4🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that